As the report noted, brain cancer can affect patients' physical and cognitive functioning. Cancer tumors' interference with brain function can also lead to challenging secondary mental disorders.

Brain cancer patients suffer a high rate of depression often caused by the stress of traditional cancer treatments such as chemotherapy and radiation treatments, as well as by the progress of their disease.

In the study, brain cancer patients who received massage therapy twice a week for four weeks experienced a remarkable decrease in stress levels. Patients who at the beginning of the study suffered from severe stress scored below diagnostic stress detection by the end of their 4-week treatment.

"This is more significant than I would have expected," Dr. Keri Peterson of the American Massage Therapy Association told Fox News.

Prior to the study, the majority of participants expressed concerns common to most cancer patients, including sadness, worry, nervousness, pain, tiredness, trouble sleeping, fear, depression, eating, constipation, nausea, dry skin and tingling sensations. At the end of the 4-week treatment protocol, concern about common cancer stressors was significantly reduced, by as much as 60% for some issues.

As a group, brain cancer patients enjoyed improved feelings of emotional, physical and social well-being. Post-treatment testing revealed that benefits began to fade when massage therapy was discontinued, although patients' stress levels remained lower than they were initially. Continued massage therapy is an option you may want to discuss with your Issels treatment specialists.

We invite you to contact one of our patient care specialists today to find out how the Issels immunobiologic core treatment program may be the right choice for your health needs. We invite you to phone 1-888-447-7357 or visit us online at www.Issels.com.

Issels has been a leader in individualized immunotherapy for over 60 years. Our extensive experience in integrating vaccines into a personalized non-toxic cancer treatment has achieved complete long-term remission of
advanced and standard-therapy resistant cancers.